Glioblastoma, the most aggressive and malignant form of primary brain cancer, has long remained a "graveyard" for...
Neng Nana
In the relentless pursuit of transforming metastatic breast cancer (MBC) from a terminal diagnosis into a manageable...
Introduction On May 8, 2026, as the global medical community and advocacy groups observed World Ovarian Cancer...
The global fight against breast cancer is entering a new era of strategic precision, fueled not only...
For decades, Bristol Myers Squibb (BMS) has cemented its status as a titan of the pharmaceutical industry...
The landscape of neurotechnology is witnessing a seismic shift as Swiss-based Neurosoft Bioelectronics announced the successful closure...
In the ongoing crusade to decipher the biological underpinnings of breast cancer, researchers have long grappled with...
In a landmark analysis set to be unveiled at the 2026 American Society of Clinical Oncology (ASCO)...
In a move that signals a seismic shift in the architecture of pharmaceutical research and development, Bristol...
In a significant move that underscores the intensifying race for innovation in the treatment of calcified arterial...
